2003
DOI: 10.1016/s0360-3016(03)00075-0
|View full text |Cite
|
Sign up to set email alerts
|

Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
180
0
1

Year Published

2004
2004
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 284 publications
(186 citation statements)
references
References 23 publications
5
180
0
1
Order By: Relevance
“…This is in agreement with the recommendations that strict normalDmax constraints are essential to maintain functionality of such critical organs 19 , 20 , 21 , 22 . However, Fig.…”
Section: Resultssupporting
confidence: 91%
See 3 more Smart Citations
“…This is in agreement with the recommendations that strict normalDmax constraints are essential to maintain functionality of such critical organs 19 , 20 , 21 , 22 . However, Fig.…”
Section: Resultssupporting
confidence: 91%
“…However, a tighter control is not necessary because the probability of myelopathy vanishes for D<40Gy to the cord (18) . These observations may be considered as an indirect effect of the predominant normalDmax constraints on brainstems and spines, as common in head‐and‐neck cases 19 , 20 , 21 , 22 . Note that normalDmax thresholds lead to V=0% at DnormalDmax, resulting in narrower IQRvol.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…It represents a major step forward in modern treatment planning. However the problem of dose inhomogenity and suboptimal coverage is still unresolved because of highly infiltrative growth pattern with a propensity to spread through skull base foramina to the intracranial structures particularly visual apparatus as well as parapharyngeal space and large neck lymph nodes, in addition, there is a variation of the anatomic structure of the nasopharynx between individuals (Kam et al, 2003). This has led the radiation oncologist to break the treatment plan into different phases that has also compromised tumor coverage.…”
Section: Plan Dose Evaluation Of Three Dimensional Conformal Radiothementioning
confidence: 99%